Efficacy And Safety Of Indacaterol 75 G Once Daily In Patients With Moderate-To-Severe COPD

被引：0
|
作者：
Kerwin, E. M.
Meli, J.
Peckitt, C.
Lassen, C.
Kramer, B.
Filcek, S.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1595
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
    Paller, Amy
    Seyger, Marieke
    Alejandro Magarinos, Gabriel
    Bagel, Jerry
    Keller, Stuart
    Capriles, Claudia Rodriguez
    Gallo, Gaia
    Edson-Heredia, Emily
    Li, Lingnan
    Xu, Wen
    Papp, Kim
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [42] Efficacy and Safety of Dupilumab in Patients With Moderate-to-Severe COPD and Type 2 Inflammation: Phase 3 NOTUS Trial
    Bhatt, S. P.
    Rabe, K. F.
    Hanania, N. A.
    Vogelmeier, C. F.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Akinlade, B.
    Maloney, J.
    Lu, X.
    Bauer, D.
    Bansal, A.
    Abdulai, R. M.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [43] Efficacy And Safety Of Aclidinium Bromide Compared With Tiotropium And Placebo In Patients With Moderate-To-Severe COPD: A Phase Iiib Study
    Beier, J.
    Kirsten, A.
    Mroz, R.
    Segarra, R.
    Chuecos, F.
    Caracta, C.
    Gil, E. Garcia
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [44] Dupilumab efficacy and safety in patients with moderate-to-severe COPD with type 2 inflammation: pooled analysis of BOREAS and NOTUS
    Bhatt, Surya
    Rabe, Klaus F.
    Hanania, Nicola
    Vogelmeier, Claus F.
    Bafadhel, Mona
    Christenson, Stephanie
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Akinlade, Bolanle
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Abdulai, Raolat M.
    Robinson, Lacey B.
    Bhatt, Surya
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [45] Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
    Talamonti, M.
    Galluzzo, M.
    Teoli, M.
    Bavetta, M.
    Chimenti, S.
    Costanzo, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E34 - E34
  • [46] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [47] Efficacy and safety of infliximab biosimilars in the treatment of patients with moderate-to-severe psoriasis
    Chasapi, Vasiliki
    Routsi, Eleni
    Lantzou, Sotiria
    Papoutsaki, Marina
    Panagakis, Pantelis
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [48] Umeclidinium/vilanterol (UMEC/VI) once daily (OD) vs fluticasone/salmeterol combination (FSC) twice daily (BD) in patients with moderate-to-severe COPD and infrequent COPD exacerbations
    Singh, D.
    Worsley, S.
    Zhu, C-Q
    Hardaker, L.
    Church, A.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [49] Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
    Melinda J. Gooderham
    Andrew E. Pink
    Eric L. Simpson
    Jonathan I. Silverberg
    Erman Güler
    Melissa Watkins
    Dermatology and Therapy, 2023, 13 : 1893 - 1907
  • [50] EFFECT OF AGE ON EFFICACY AND SAFETY OF ONCE-DAILY UMECLIDINIUM IN PATIENTS WITH COPD
    Soule, Tedi
    Caveney, Scott
    Tombs, Lee
    Naya, Ian
    Boucot, Isabelle
    CHEST, 2018, 154 (04) : 750A - 750A
12345